Tag: convenience

DELRAY BEACH, Fla., July 23, 2025 /PRNewswire/ -- According to MarketsandMarkets™, The modified cassava starch market is projected to grow from USD 2.52 billion in...

PASAY CITY, Philippines, July 23, 2025 /PRNewswire/ -- The SM Group is firming up its commitment to reduce plastic waste as a shared responsibility...

PASAY CITY, Philippines, July 23, 2025 /PRNewswire/ -- The SM Group is firming up its commitment to reduce plastic waste as a shared responsibility...

PASAY CITY, Philippines, July 23, 2025 /PRNewswire/ -- The SM Group is firming up its commitment to reduce plastic waste as a shared responsibility...

ZUG, Switzerland, July 22, 2025 (GLOBE NEWSWIRE) -- Pharvaris N.V. (“Pharvaris,” Nasdaq: PHVS), a late-stage biopharmaceutical company developing novel, oral bradykinin B2 receptor antagonists to address unmet needs of those living with bradykinin-mediated diseases such as hereditary angioedema (HAE) and acquired angioedema due to C1 inhibitor deficiency (AAE-C1INH), announced today the pricing of an underwritten offering of (i) 8,250,000 of its ordinary shares at a price of $20.00 per share and (ii) to one investor, pre-funded warrants to purchase 500,000 ordinary shares at a price of $19.99 per pre-funded warrant, which represents the per share public offering price for the ordinary shares less the $0.01 per share exercise price for each such pre-funded warrant. All shares and pre-funded warrants in the offering are to be sold by Pharvaris. In addition, Pharvaris has granted the underwriters a 30-day option to purchase up to an additional 1,312,500 ordinary shares at the public offering price, less underwriting discounts and commissions. The gross proceeds to Pharvaris from the offering, before deducting underwriting discounts and commissions and offering expenses, are expected to be approximately $175 million, excluding any exercise of the underwriters’ option to purchase additional shares. The offering is expected to close on or about July 24, 2025, subject to satisfaction of customary closing conditions.

NEW YORK, July 22, 2025 /PRNewswire/ -- Blazing Star Merger Sub, Inc. (the "Offeror" announced today the commencement of cash tender offers (each, an...

CALGARY, AB, July 22, 2025 /PRNewswire-HISPANIC PR WIRE/ -- Parkland Corporation ("Parkland", "we", the "Company", or "our") (TSX: PKI) expects to announce its 2025...

CALGARY, AB, July 22, 2025 /PRNewswire/ - Parkland Corporation ("Parkland", "we", the "Company", or "our") (TSX: PKI) expects to announce its 2025 second quarter...

CALGARY, AB, July 22, 2025 /CNW/ - Parkland Corporation ("Parkland", "we", the "Company", or "our") (TSX: PKI) expects to announce its 2025 second quarter...

7th annual contest celebrates excellence in innovation HOUSTON, July 22, 2025 /PRNewswire/ -- Franchise Update Media conducted its 7th annual Franchise Innovation Awards contest this...

NIU installs four off-grid solar charging benches with Bluebolt Outdoor, offering device charging and supporting campus sustainability efforts.

TUCSON, Ariz., July 22, 2025 /PRNewswire/ -- Group2FA®, the pioneering provider of multiuser two-factor authentication (2FA) for shared accounts, today announced several new features...

SAN DIEGO, July 22, 2025 /PRNewswire/ -- Halozyme Therapeutics, Inc. (NASDAQ: HALO) ("Halozyme") today announced it will release its second quarter 2025 financial and...